Fosun Pharma continues share repurchase program in April 2025

Shanghai Fosun Pharmaceutical Group (SSE: 600196) has announced continued progress on its share repurchase programs in April 2025. The company repurchased 5,697,252 A-shares, representing approximately 0.2133% of the total share capital, for approximately CNY 13.498 million. The highest A-share repurchase price was CNY 24.03 per share and the lowest was CNY 23.34 per share. As of April 30, 2025, Fosun Pharma had cumulatively repurchased 7,310,552 A-shares, accounting for 0.2737% of total share capital, at prices ranging from CNY 23.34 to CNY 25.39 per share, for a total of CNY 17.497 million.